DEO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Diageo PLC (DEO) is not a strong buy at this time for a beginner investor with a long-term focus. The stock is currently in a bearish trend with weak technical indicators, declining financial performance, and mixed analyst ratings. While hedge funds are increasing their positions, the lack of significant positive catalysts and the recent dividend cut make it prudent to hold off on investing for now.
The technical indicators for DEO show a bearish trend. The MACD histogram is negative and expanding, RSI is neutral at 24.149, and moving averages indicate a downward trajectory (SMA_200 > SMA_20 > SMA_5). Key support levels are at S1: 87.946 and S2: 83.793, with resistance at R1: 101.393. The stock is trading below its pivot point of 94.669, signaling further downside potential.
Hedge funds have significantly increased their buying activity, up 7225.13% over the last quarter. Analyst upgrades, such as RBC Capital's upgrade to Outperform, highlight the company's strong brand portfolio and reduced spending.
Diageo reported a 3% decline in organic sales and adjusted EPS for H1 FY26, alongside a reduced dividend. Net sales fell short of expectations at $10.5 billion, with competitive pressures and changing consumer preferences negatively impacting performance. Analysts like UBS and Morgan Stanley have downgraded the stock, citing downside risks in the U.S. spirits market. Technical indicators and stock trends suggest further declines in the short term.
Diageo's financial performance for H1 FY26 was weak, with a 3% decline in organic sales and adjusted EPS. Net sales were $10.5 billion, falling short of expectations, and the company reduced its dividend to strengthen its balance sheet. This reflects challenges in maintaining growth and profitability.
Analyst sentiment is mixed. RBC Capital upgraded the stock to Outperform, citing strong brand assets and reduced spending. However, UBS downgraded it to Neutral, citing underperformance and risks in the U.S. spirits market. Morgan Stanley also lowered its price target, maintaining an Underweight rating. Barclays remains optimistic with an Overweight rating but reduced its price target.
